Sign in

Private company

Regenicin, Inc.

Regenicin, Inc. is an American surgical and medical instruments and apparatus company.1 It is headquartered in Las Vegas, Nevada.1

Last updated Oct 21, 2026.

Overview

  • IndustrySurgical & Medical Instruments & Apparatus1
  • HeadquartersLas Vegas, Nevada1
  • Incorporated inNV2
  • Business address10530 Discovery Dr, Las Vegas, Nv 074242
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income345678-$635.9K in 2021+163% since 2015
-$1.0M-$750.0K-$500.0K-$250.0K02015: -$241.8K-$241.8K20152016: -$779.9K-$779.9K2016+222%2017: -$961.1K-$961.1K2017+23%2018: -$540.3K-$540.3K2018−44%2019: -$736.6K-$736.6K2019+36%2020: -$510.8K-$510.8K2020−31%2021: -$635.9K-$635.9K2021+24%
Net income345679-$639.3K in 2021
-$1.0M0$1.0M$2.0M2015: $242.6K$242.6K20152016: $1.1M$1.1M2016+349%2017: -$973.9K-$973.9K20172018: $559.1K$559.1K20182019: $758.5K$758.5K2019+36%2020: -$670.6K-$670.6K20202021: -$639.3K-$639.3K2021−5%
Fiscal year20152016201720182019202020212022
Research and development$38.4K3$1.4K4$5.3K5
Operating income-$241.8K3-$779.9K4-$961.1K5-$540.3K6-$736.6K7-$510.8K8-$635.9K8
Interest$18.0K7-$34.7K9-$36.3K9
Income tax$2.8M3
Net income$242.6K3$1.1M4-$973.9K5$559.1K6$758.5K7-$670.6K9-$639.3K9

Compare Regenicin, Inc. with another company

Corporate structure

Regenicin, Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Regenicin, Inc.

  • Truist Financial Filed SC 13G/A on Regenicin, Inc., latest Mar 23, 2022 (2 filings since Mar 17, 2022)
  • Regenicin, Inc. Las Vegas, Nevada

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

Former names

  • Windstar Inc.Oct 22, 2007 to Jul 15, 20102

Timeline

  1. Dec 23, 20248-K Other events13
  2. Dec 23, 20248-K Other events14
  3. Nov 22, 20248-K Other events15
  4. Nov 15, 20248-K Other events16
  5. Nov 12, 20248-K Other events17
  6. Nov 6, 20248-K Change of auditor18
  7. Sep 14, 20238-K Change of auditor19

Filings

22 filings to the SEC since October 2021: 4 annual reports, 6 quarterly reports, 7 major events, 2 large holders, 3 other. The latest 20:

  1. Dec 23, 20248-K/A EDGAR
  2. Dec 23, 20248-K EDGAR
  3. Nov 22, 20248-K/A EDGAR
  4. Nov 15, 20248-K/A EDGAR
  5. Nov 12, 20248-K EDGAR
  6. Nov 6, 20248-K EDGAR
  7. Sep 14, 20238-K EDGAR
  8. May 15, 202310-Q EDGAR
  9. Feb 13, 202310-Q EDGAR
  10. Jan 13, 202310-K EDGAR
  11. Dec 27, 2022NT 10-K EDGAR
  12. Aug 12, 202210-Q EDGAR
  13. May 23, 202210-Q EDGAR
  14. May 16, 2022NT 10-Q EDGAR
  15. Mar 25, 202210-Q/A EDGAR
  16. Mar 25, 202210-K/A EDGAR
  17. Mar 23, 2022SC 13G/A EDGAR
  18. Mar 17, 2022SC 13G EDGAR
  19. Feb 14, 202210-Q EDGAR
  20. Feb 8, 202210-K/A EDGAR

The 22 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Regenicin, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARRegenicin, Inc.1
  • CIK0001412659
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inNevada1
  • Fiscal year endsSeptember 301
  • Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address10530 Discovery Dr, Las Vegas, NV 074241
  • Phone(800) 211-63481
  • Shares outstanding153,483,050 as of Apr 4, 202311
  • Public float$1.5M as of Dec 31, 20229
  • On EDGAR sinceOct 22, 20071
  • Filings183 in all: 10-Q (46), 8-K (38), NT 10-Q (25), 10-K (15), NT 10-K (15), UPLOAD (9), 8-K/A (7), CORRESP (6)1
    All 17 form types

    SC 13G (5), 10-K/A (4), 10-Q/A (3), POS AM (3), D (2), EFFECT (2), 10QSB (1), SB-2 (1), SC 13G/A (1)

  • Latest filingsAnnual report (10-K) Jan 13, 2023
    Quarterly report (10-Q) May 15, 2023
    Latest 8-K (8-K) Dec 23, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
    SEC EDGAROther events
  14. 14
    SEC EDGAROther events
  15. 15
    SEC EDGAROther events
  16. 16
    SEC EDGAROther events
  17. 17
    SEC EDGAROther events
  18. 18
  19. 19
  20. 20